Medical therapy to facilitate urinary stone passage: a meta-analysis

Lancet

Volumn 368, Issue 9542, 2006, Pages 1171-1179

  Hollingsworth, John M ^a   Rogers, Mary AM ^b,c   Kaufman, Samuel R ^b,c   Bradford, Timothy J ^a   Saint, Sanjay ^b,c,d   Wei, John T ^a   Hollenbeck, Brent K ^a  

^a Department of Urology ^*  (United States)

^b Department of Internal Medicine   (United States)

^c Veterans Affairs/University   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIAZEPAM; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; TAMSULOSIN; TERAZOSIN;

ARTICLE; CINAHL; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFICACY; EMBASE; HEART PALPITATION; HUMAN; HYPOTENSION; MEDLINE; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URETER STONE; UROLITHIASIS;

EID: 33748957347     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69474-9     Document Type: Article

References (55)

1. Ljunghall S. Renal stone disease. Studies of epidemiology and calcium metabolism. Scan J Urol Nephrol 41 (1977) 1-96
2. Pak C., Resnick M., and Preminger G. Ethnic and geographic diversity of stone disease. Urology 50 (1997) 504-507
3. Tiselius H. Epidemiology and medical management of stone disease. BJU Int 91 (2003) 758-767
4. Sierakowski R., Finlayson B., Landes R., Finlayson C., and Sierakowski N. The frequency of urolithiasis in hospital discharge diagnoses in the United States. Invest Urol 15 (1978) 438-441
5. Stamatelou K., Francis M., Jones C., Nyberg L., and Curhan G. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63 (2003) 1817-1823
6. Coe F., Keck J., and Norton E. The natural history of calcium urolithiasis. JAMA 238 (1977) 1519-1523
7. Pearle M., Calhoun E., and Curhan G. Urologic Diseases of America Project. Urologic diseases in America project: urolithiasis. J Urol 173 (2005) 848-857
8. Hubner W., Irby P., and Stoller M. Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol 24 (1993) 172-176
9. Miller O., and Kane C. Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol 162 (1999) 688-690
10. Ueno A., Kawamura T., Ogawa A., and Takayasu H. Relation of spontaneous passage of ureteral calculi to size. Urology 10 (1977) 544-546
11. Sigala S., Dellabella M., Milanese G., et al. Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn 24 (2005) 142-148
12. Laird J., Roza C., and Cervero F. Effects of artificial calculosis on rat ureter motility: peripheral contribution to the pain of ureteric colic. Am J Physiol 272 (1997) R1409-R1416
13. Maggi C., and Giuliani S. A pharmacological analysis of calcium channels involved in phasic and tonic responses of the guinea-pig ureter to high potassium. J Auton Pharmacol 15 (1995) 55-64
14. Malin J., Deane R., and Boyarsky S. Characterisation of adrenergic receptors in human ureter. Br J Urol 42 (1970) 171-174
15. Morita T., Wada I., Suzuki T., and Tsuchida S. Characterization of alpha-adrenoceptor subtypes involved in regulation of ureteral fluid transport. Tohoku J Exp Med 152 (1987) 111-118
16. Salman S., Castilla C., and Vela N. Action of calcium antagonists on ureteral dynamics. Actas Urol Esp 13 (1989) 150-152
17. Sivula A., and Lehtonen T. Spontaneous passage of artificial concretions applied in the rabbit ureter. Scan J Urol Nephrol 1 (1967) 259-263
18. Bierkens A., Hendrikx A., De La Rosette J., et al. Treatment of mid- and lower ureteric calculi: extracorporeal shock-wave lithotripsy vs laser ureteroscopy. A comparison of costs, morbidity and effectiveness. Br J Urol 81 (1998) 31-35
19. Hochreiter W., Danuser H., Perrig M., and Studer U. Extracorporeal shock wave lithotripsy for distal ureteral calculi: what a powerful machine can achieve. J Urol 169 (2003) 878-880
20. Rubin J., Arger P., Pollack H., Banner M., Coleman B., and Mintz M. Kidney changes after extracorporeal shock wave lithotripsy: CT evaluation. Radiology 162 (1987) 21-24
21. Harmon W., Sershon P., Blute M., Patterson D., and Segura J. Ureteroscopy: current practice and long-term complications. J Urol 157 (1997) 28-32
22. Schuster T., Hollenbeck B., Faerber G., and Wolf J. Complications of ureteroscopy: analysis of predictive factors. J Urol 166 (2001) 538-540
23. Daniels G., Garnett J., and Carter M. Ureteroscopic results and complications: experience with 130 cases. J Urol 139 (1988) 710-713
24. el-Faqih S., Husain I., Ekman P., Sharma N., Chakrabarty A., and Talic R. Primary choice of intervention for distal ureteric stone: ureteroscopy or ESWL?. Br J Urol 62 (1988) 13-18
25. Kramolowsky E. Ureteral perforation during ureterorenoscopy: treatment and management. J Urol 138 (1987) 36-38
26. Lotan Y., Gettman M., Roehrborn C., Cadeddu J., and Pearle M. Management of ureteral calculi: a cost comparison and decision making analysis. J Urol 167 (2002) 1621-1629
27. Preminger G. Sonographic piezoelectric lithotripsy: more bang for your buck. In: Lingeman J., and Newman D. (Eds). Shock wave lithotripsy urinary and biliary lithotripsy (1989), Plenum, New York 437-443
28. Moher D., Cook D., Eastwood S., Olkin I., Rennie D., Stroup D., and for the QUOROM Group. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 354 (1999) 1896-1900
29. Higgins J., and Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
30. Newcombe R. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 17 (1998) 873-890
31. Rosenthal R. The 'file drawer problem' and tolerance for null results. Psychol Bull 86 (1979) 638-641
32. Rosenberg M. The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis. Evolution Int J Org Evolution 59 (2005) 464-468
33. Cochrane handbook for systematic reviews of interventions 4.2.5). In: Higgins J., and Green S. (Eds). The Cochrane Library, Issue 3, 2005 (2005), John Wiley & Sons, Chichester, UK
34. Borghi L., Meschi T., Amato F., et al. Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J Urol 152 (1994) 1095-1098
35. Cervenakov I., Fillo J., Mardiak J., Kopecny M., Smirala J., and Lepies P. Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker-Tamsulosin. Int Urol Nephrol 34 (2002) 25-29
36. Dellabella M., Milanese G., and Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170 (2003) 2202-2205
37. Dellabella M., Milanese G., and Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 174 (2005) 167-172
38. Staerman F., Bryckaert P., Colin J., Youinou Y., Brandt B., and Lardennois B. Nifedipine in the medical treatment of symptomatic distal ureteral calculi. Eur Urol 37 (2005) 28
39. Salehi M., Fouladi M., Shier H., Mokhtari G., and Dejabad V. Does methylprednisolone acetate increase the success rate of medical therapy for patients with distal ureteral stones. Eur Urol Suppl 4 (2005) 25
40. Cooper J., Stack G., and Cooper T. Intensive medical management of ureteral calculi. Urology 56 (2000) 575-578
41. Kupeli B., Irkilata L., Gurocak S., et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy?. Urology 64 (2004) 1111-1115
42. Porpiglia F., Destefanis P., Fiori C., and Fontana D. Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology 56 (2000) 579-582
43. Porpiglia F., Ghignone G., Fiori C., Fontana D., and Scarpa R. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 172 (2004) 568-571
44. Resim S., Ekerbicer H., and Ciftci A. Effect of tamsulosin on the number and intensity of ureteral colic in patients with lower ureteral calculus. Int J Urol 12 (2005) 615-620
45. Skrekas T., Liapis D., Kalantzis A., Argyropoulos A., Doumas K., and Lycourinas M. Increasing the success rate of medical therapy for expulsion of distal ureteral stones using adjunctive treatment with calcium channel blocker. Eur Urol Suppl 2 (2003) 82
46. Yilmaz E., Batislam E., Basar M., Tuglu D., Ferhat M., and Basar H. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol 173 (2005) 2010-2012
47. Cordell W., Larson T., Lingeman J., et al. Indomethacin suppositories versus intravenously titrated morphine for the treatment of ureteral colic. Ann Emerg Med 23 (1994) 262-269
48. Cordell W., Wright S., Wolfson A., et al. Comparison of intravenous ketorolac, meperidine, and both (balanced analgesia) for renal colic. Ann Emerg Med 28 (1996) 151-158
49. Al-Waili N. Prostaglandin synthetase inhibition with indomethacin rectal suppositories in the treatment of acute and chronic urinary calculus obstruction. Clin Exp Pharmacol Physiol 13 (1986) 195-199
50. Ahmad M., Chaughtai M., and Khan F. Role of prostaglandin synthesis inhibitors in the passage of ureteric calculus. JPMA J Pakistan Med Assoc 41 (1991) 268-270
51. Laerum E., Ommundsen O., Gronseth J., Christiansen A., and Fagertun H. Oral diclofenac in the prophylactic treatment of recurrent renal colic. A double-blind comparison with placebo. Eur Urol 28 (1995) 108-111
52. Taghavi R., Darabi M., Tavakoli K., and Keshvari M. Survey of the effect of tamsulosin and nifedipine on facilitating juxtavesical ureteral stone passage. J Endourol 19 suppl 1 (2005) A9
53. Tekin A., Alkan E., Beysel M., Yucebas E., Asian R., and Sengor F. Alpha-1 receptor blocking therapy for lower ureteral stones: a randomized prospective trial. J Urol 17 suppl 4 (2004) 304
54. Gerber R., Studer U., and Danuser H. Is newer always better? A comparative study of 3 lithotriptor generations. J Urol 173 (2005) 2013-2016
55. Thornton A., and Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 53 (2000) 207-216